Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that primarily affects the lining of the synovial joints and is associated with progressive disability, premature death, and socioeconomic burdens.the implantable joint prostheses segment accounted for the largest share of the total rheumatoid arthritis market, whereas the spinal devices segment expected to witness double-digit growth rate in the coming years.
The global Rheumatoid Arthritis Devices market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Rheumatoid Arthritis Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Rheumatoid Arthritis Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Rheumatoid Arthritis Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Rheumatoid Arthritis Devices include Active Implants LLC, Anika Therapeutics, Inc., Arthrex, Inc., Asahi Kasei Pharma Corporation, B. Braun Melsungen AG, CONMED Corporation, EMulate Therapeutics, Inc. (Nativis, Inc.), Integra Lifesciences Corporation and Johnson & Johnson (DePuy Synthes Inc.), etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for Rheumatoid Arthritis Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Rheumatoid Arthritis Devices, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Rheumatoid Arthritis Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rheumatoid Arthritis Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Rheumatoid Arthritis Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Rheumatoid Arthritis Devices sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Active Implants LLC, Anika Therapeutics, Inc., Arthrex, Inc., Asahi Kasei Pharma Corporation, B. Braun Melsungen AG, CONMED Corporation, EMulate Therapeutics, Inc. (Nativis, Inc.), Integra Lifesciences Corporation and Johnson & Johnson (DePuy Synthes Inc.), etc.
By Company
Active Implants LLC
Anika Therapeutics, Inc.
Arthrex, Inc.
Asahi Kasei Pharma Corporation
B. Braun Melsungen AG
CONMED Corporation
EMulate Therapeutics, Inc. (Nativis, Inc.)
Integra Lifesciences Corporation
Johnson & Johnson (DePuy Synthes Inc.)
Novartis AG
RTI Surgical, Inc.
Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
Setpoint Medical Corporation
Smith & Nephew plc (Osiris Therapeutics, Inc.)
Stryker Corporation (OrthoSpace Ltd.)
UCB Pharma S.A.
Zimmer Biomet
Segment by Type
Implantable Joint Prostheses
Spinal Devices
Other
Segment by Application
Elderly
Young adults
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Rheumatoid Arthritis Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Rheumatoid Arthritis Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rheumatoid Arthritis Devices sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Rheumatoid Arthritis Devices Product Introduction
1.2 Market by Type
1.2.1 Global Rheumatoid Arthritis Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Implantable Joint Prostheses
1.2.3 Spinal Devices
1.2.4 Other
1.3 Market by Application
1.3.1 Global Rheumatoid Arthritis Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Elderly
1.3.3 Young adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rheumatoid Arthritis Devices Sales Estimates and Forecasts 2018-2029
2.2 Global Rheumatoid Arthritis Devices Revenue by Region
2.2.1 Global Rheumatoid Arthritis Devices Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Rheumatoid Arthritis Devices Revenue by Region (2018-2023)
2.2.3 Global Rheumatoid Arthritis Devices Revenue by Region (2024-2029)
2.2.4 Global Rheumatoid Arthritis Devices Revenue Market Share by Region (2018-2029)
2.3 Global Rheumatoid Arthritis Devices Sales Estimates and Forecasts 2018-2029
2.4 Global Rheumatoid Arthritis Devices Sales by Region
2.4.1 Global Rheumatoid Arthritis Devices Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Rheumatoid Arthritis Devices Sales by Region (2018-2023)
2.4.3 Global Rheumatoid Arthritis Devices Sales by Region (2024-2029)
2.4.4 Global Rheumatoid Arthritis Devices Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rheumatoid Arthritis Devices Sales by Manufacturers
3.1.1 Global Rheumatoid Arthritis Devices Sales by Manufacturers (2018-2023)
3.1.2 Global Rheumatoid Arthritis Devices Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rheumatoid Arthritis Devices in 2022
3.2 Global Rheumatoid Arthritis Devices Revenue by Manufacturers
3.2.1 Global Rheumatoid Arthritis Devices Revenue by Manufacturers (2018-2023)
3.2.2 Global Rheumatoid Arthritis Devices Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Devices Revenue in 2022
3.3 Global Key Players of Rheumatoid Arthritis Devices, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Rheumatoid Arthritis Devices Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rheumatoid Arthritis Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rheumatoid Arthritis Devices, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rheumatoid Arthritis Devices, Product Offered and Application
3.8 Global Key Manufacturers of Rheumatoid Arthritis Devices, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rheumatoid Arthritis Devices Sales by Type
4.1.1 Global Rheumatoid Arthritis Devices Historical Sales by Type (2018-2023)
4.1.2 Global Rheumatoid Arthritis Devices Forecasted Sales by Type (2024-2029)
4.1.3 Global Rheumatoid Arthritis Devices Sales Market Share by Type (2018-2029)
4.2 Global Rheumatoid Arthritis Devices Revenue by Type
4.2.1 Global Rheumatoid Arthritis Devices Historical Revenue by Type (2018-2023)
4.2.2 Global Rheumatoid Arthritis Devices Forecasted Revenue by Type (2024-2029)
4.2.3 Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2018-2029)
4.3 Global Rheumatoid Arthritis Devices Price by Type
4.3.1 Global Rheumatoid Arthritis Devices Price by Type (2018-2023)
4.3.2 Global Rheumatoid Arthritis Devices Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Rheumatoid Arthritis Devices Sales by Application
5.1.1 Global Rheumatoid Arthritis Devices Historical Sales by Application (2018-2023)
5.1.2 Global Rheumatoid Arthritis Devices Forecasted Sales by Application (2024-2029)
5.1.3 Global Rheumatoid Arthritis Devices Sales Market Share by Application (2018-2029)
5.2 Global Rheumatoid Arthritis Devices Revenue by Application
5.2.1 Global Rheumatoid Arthritis Devices Historical Revenue by Application (2018-2023)
5.2.2 Global Rheumatoid Arthritis Devices Forecasted Revenue by Application (2024-2029)
5.2.3 Global Rheumatoid Arthritis Devices Revenue Market Share by Application (2018-2029)
5.3 Global Rheumatoid Arthritis Devices Price by Application
5.3.1 Global Rheumatoid Arthritis Devices Price by Application (2018-2023)
5.3.2 Global Rheumatoid Arthritis Devices Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Rheumatoid Arthritis Devices Market Size by Type
6.1.1 US & Canada Rheumatoid Arthritis Devices Sales by Type (2018-2029)
6.1.2 US & Canada Rheumatoid Arthritis Devices Revenue by Type (2018-2029)
6.2 US & Canada Rheumatoid Arthritis Devices Market Size by Application
6.2.1 US & Canada Rheumatoid Arthritis Devices Sales by Application (2018-2029)
6.2.2 US & Canada Rheumatoid Arthritis Devices Revenue by Application (2018-2029)
6.3 US & Canada Rheumatoid Arthritis Devices Market Size by Country
6.3.1 US & Canada Rheumatoid Arthritis Devices Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Rheumatoid Arthritis Devices Sales by Country (2018-2029)
6.3.3 US & Canada Rheumatoid Arthritis Devices Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rheumatoid Arthritis Devices Market Size by Type
7.1.1 Europe Rheumatoid Arthritis Devices Sales by Type (2018-2029)
7.1.2 Europe Rheumatoid Arthritis Devices Revenue by Type (2018-2029)
7.2 Europe Rheumatoid Arthritis Devices Market Size by Application
7.2.1 Europe Rheumatoid Arthritis Devices Sales by Application (2018-2029)
7.2.2 Europe Rheumatoid Arthritis Devices Revenue by Application (2018-2029)
7.3 Europe Rheumatoid Arthritis Devices Market Size by Country
7.3.1 Europe Rheumatoid Arthritis Devices Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Rheumatoid Arthritis Devices Sales by Country (2018-2029)
7.3.3 Europe Rheumatoid Arthritis Devices Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rheumatoid Arthritis Devices Market Size
8.1.1 China Rheumatoid Arthritis Devices Sales (2018-2029)
8.1.2 China Rheumatoid Arthritis Devices Revenue (2018-2029)
8.2 China Rheumatoid Arthritis Devices Market Size by Application
8.2.1 China Rheumatoid Arthritis Devices Sales by Application (2018-2029)
8.2.2 China Rheumatoid Arthritis Devices Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Rheumatoid Arthritis Devices Market Size by Type
9.1.1 Asia Rheumatoid Arthritis Devices Sales by Type (2018-2029)
9.1.2 Asia Rheumatoid Arthritis Devices Revenue by Type (2018-2029)
9.2 Asia Rheumatoid Arthritis Devices Market Size by Application
9.2.1 Asia Rheumatoid Arthritis Devices Sales by Application (2018-2029)
9.2.2 Asia Rheumatoid Arthritis Devices Revenue by Application (2018-2029)
9.3 Asia Rheumatoid Arthritis Devices Sales by Region
9.3.1 Asia Rheumatoid Arthritis Devices Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Rheumatoid Arthritis Devices Revenue by Region (2018-2029)
9.3.3 Asia Rheumatoid Arthritis Devices Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rheumatoid Arthritis Devices Market Size by Type
10.1.1 Middle East, Africa and Latin America Rheumatoid Arthritis Devices Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Rheumatoid Arthritis Devices Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Rheumatoid Arthritis Devices Market Size by Application
10.2.1 Middle East, Africa and Latin America Rheumatoid Arthritis Devices Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Rheumatoid Arthritis Devices Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Rheumatoid Arthritis Devices Sales by Country
10.3.1 Middle East, Africa and Latin America Rheumatoid Arthritis Devices Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Rheumatoid Arthritis Devices Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Rheumatoid Arthritis Devices Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Active Implants LLC
11.1.1 Active Implants LLC Company Information
11.1.2 Active Implants LLC Overview
11.1.3 Active Implants LLC Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Active Implants LLC Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Active Implants LLC Recent Developments
11.2 Anika Therapeutics, Inc.
11.2.1 Anika Therapeutics, Inc. Company Information
11.2.2 Anika Therapeutics, Inc. Overview
11.2.3 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Anika Therapeutics, Inc. Recent Developments
11.3 Arthrex, Inc.
11.3.1 Arthrex, Inc. Company Information
11.3.2 Arthrex, Inc. Overview
11.3.3 Arthrex, Inc. Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Arthrex, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Arthrex, Inc. Recent Developments
11.4 Asahi Kasei Pharma Corporation
11.4.1 Asahi Kasei Pharma Corporation Company Information
11.4.2 Asahi Kasei Pharma Corporation Overview
11.4.3 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Asahi Kasei Pharma Corporation Recent Developments
11.5 B. Braun Melsungen AG
11.5.1 B. Braun Melsungen AG Company Information
11.5.2 B. Braun Melsungen AG Overview
11.5.3 B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 B. Braun Melsungen AG Recent Developments
11.6 CONMED Corporation
11.6.1 CONMED Corporation Company Information
11.6.2 CONMED Corporation Overview
11.6.3 CONMED Corporation Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 CONMED Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CONMED Corporation Recent Developments
11.7 EMulate Therapeutics, Inc. (Nativis, Inc.)
11.7.1 EMulate Therapeutics, Inc. (Nativis, Inc.) Company Information
11.7.2 EMulate Therapeutics, Inc. (Nativis, Inc.) Overview
11.7.3 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 EMulate Therapeutics, Inc. (Nativis, Inc.) Recent Developments
11.8 Integra Lifesciences Corporation
11.8.1 Integra Lifesciences Corporation Company Information
11.8.2 Integra Lifesciences Corporation Overview
11.8.3 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Integra Lifesciences Corporation Recent Developments
11.9 Johnson & Johnson (DePuy Synthes Inc.)
11.9.1 Johnson & Johnson (DePuy Synthes Inc.) Company Information
11.9.2 Johnson & Johnson (DePuy Synthes Inc.) Overview
11.9.3 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Johnson & Johnson (DePuy Synthes Inc.) Recent Developments
11.10 Novartis AG
11.10.1 Novartis AG Company Information
11.10.2 Novartis AG Overview
11.10.3 Novartis AG Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Novartis AG Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis AG Recent Developments
11.11 RTI Surgical, Inc.
11.11.1 RTI Surgical, Inc. Company Information
11.11.2 RTI Surgical, Inc. Overview
11.11.3 RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 RTI Surgical, Inc. Recent Developments
11.12 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
11.12.1 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Company Information
11.12.2 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Overview
11.12.3 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Recent Developments
11.13 Setpoint Medical Corporation
11.13.1 Setpoint Medical Corporation Company Information
11.13.2 Setpoint Medical Corporation Overview
11.13.3 Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Setpoint Medical Corporation Recent Developments
11.14 Smith & Nephew plc (Osiris Therapeutics, Inc.)
11.14.1 Smith & Nephew plc (Osiris Therapeutics, Inc.) Company Information
11.14.2 Smith & Nephew plc (Osiris Therapeutics, Inc.) Overview
11.14.3 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Smith & Nephew plc (Osiris Therapeutics, Inc.) Recent Developments
11.15 Stryker Corporation (OrthoSpace Ltd.)
11.15.1 Stryker Corporation (OrthoSpace Ltd.) Company Information
11.15.2 Stryker Corporation (OrthoSpace Ltd.) Overview
11.15.3 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Stryker Corporation (OrthoSpace Ltd.) Recent Developments
11.16 UCB Pharma S.A.
11.16.1 UCB Pharma S.A. Company Information
11.16.2 UCB Pharma S.A. Overview
11.16.3 UCB Pharma S.A. Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 UCB Pharma S.A. Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 UCB Pharma S.A. Recent Developments
11.17 Zimmer Biomet
11.17.1 Zimmer Biomet Company Information
11.17.2 Zimmer Biomet Overview
11.17.3 Zimmer Biomet Rheumatoid Arthritis Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Zimmer Biomet Rheumatoid Arthritis Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Zimmer Biomet Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rheumatoid Arthritis Devices Industry Chain Analysis
12.2 Rheumatoid Arthritis Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rheumatoid Arthritis Devices Production Mode & Process
12.4 Rheumatoid Arthritis Devices Sales and Marketing
12.4.1 Rheumatoid Arthritis Devices Sales Channels
12.4.2 Rheumatoid Arthritis Devices Distributors
12.5 Rheumatoid Arthritis Devices Customers
13 Market Dynamics
13.1 Rheumatoid Arthritis Devices Industry Trends
13.2 Rheumatoid Arthritis Devices Market Drivers
13.3 Rheumatoid Arthritis Devices Market Challenges
13.4 Rheumatoid Arthritis Devices Market Restraints
14 Key Findings in The Global Rheumatoid Arthritis Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Active Implants LLC
Anika Therapeutics, Inc.
Arthrex, Inc.
Asahi Kasei Pharma Corporation
B. Braun Melsungen AG
CONMED Corporation
EMulate Therapeutics, Inc. (Nativis, Inc.)
Integra Lifesciences Corporation
Johnson & Johnson (DePuy Synthes Inc.)
Novartis AG
RTI Surgical, Inc.
Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
Setpoint Medical Corporation
Smith & Nephew plc (Osiris Therapeutics, Inc.)
Stryker Corporation (OrthoSpace Ltd.)
UCB Pharma S.A.
Zimmer Biomet
听
听
*If Applicable.
